Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04728750
Other study ID # FT7831
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2020
Est. completion date January 2, 2021

Study information

Verified date January 2021
Source Tecnologico de Monterrey
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The present study describes a 32-year-old female patient, in whom a preoperative imaging diagnosis confirmed a mass in the junction of the body and tail of the pancreas. Based on the anamnesis, on the preoperative diagnosis, and on the general status of the patient, the decision was made to performed laparoscopic enucleation of the pancreatic tumor. The operation and postoperative recovery passed without complications. A minimally invasive surgical approach should be applied whenever the dimensions and the localization of the tumor permits it, bearing in mind all the benefits and advantages that this surgical technique has to offer.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date January 2, 2021
Est. primary completion date January 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Patients with benign tumor of the pancreas - Patients with a size tumor of less than 3 cm on the pancreas Exclusion Criteria: - Patients with a size tumor greater than 3 cm on the pancreas - Malignant tumors of the pancreas

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Enucleation of a tumor of the pancreas
Enucleation of a tumor in the pancreas is feasible and safe, as it offers a minimally invasive approach, and morbidities are fewer than open or conventional approach

Locations

Country Name City State
Mexico Escuela Nacional de Medicina, Tecnologico de Monterrey Monterrey Nuevo Leon

Sponsors (1)

Lead Sponsor Collaborator
Tecnologico de Monterrey

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complete enucleation of a tumor in the pancreas Performance of a laparoscopic enucleation of a tumor in the pancreas, and compared it with a conventional approach December 2020
See also
  Status Clinical Trial Phase
Recruiting NCT04851119 - Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Phase 1/Phase 2